Watch again as experts present their highlights in skin cancer from this year’s ESMO meeting and discuss how they may impact practice:
- Game Changers in skin cancer
- Adjuvant & neoadjuvant therapy in melanoma – feat. SWOG S1801, IMMUNED
- Metastatic melanoma updates – feat. TILs in unresectable advanced melanoma
- Non-melanoma skin cancer updates – feat. ADMEC-O, neoadjuvant cemiplimab in cSCC
Game Changers in skin cancer
Adjuvant & neoadjuvant therapy in melanoma
Metastatic melanoma updates
Non-melanoma skin cancer updates
These events were supported by unrestricted educational grants and created independently by the limbic in collaboration with the hosts and panels. All studies were selected by the panels and all views expressed are those of the hosts and panels only.